Developer docs
API playgroundTry for free, no card

Search company profiles

LifeSignals

Full company profile

uuid0002h2i

Namestring
LifeSignals
Legal namestring
LifeSignals Group, Inc.
Websiteurl
lifesignals.com
Company typeenum
Private
Founded yearint
2008
Descriptiontext

LifeSignals is a privately held medical device company headquartered in Milpitas, California, with an engineering and operations center in Bangalore, India. Founded in 2006, the company designs and manufactures clinical-grade disposable wireless biosensors and the UbiqVue cloud-based patient monitoring platform for continuous vital sign capture across hospital, ambulatory, and home care settings. Its core technical asset is the LifeSignals Processor (LSP), a patented single-use wireless System-on-Chip that integrates a Wi-Fi-centric multi-radio (with Bluetooth, MBAN, and UWB), an ARM Cortex-M0 processor, onboard data storage, and AES encryption onto a single chip. The company holds 20+ patents in the US, UK, and Europe and has secured FDA 510(k), CE Mark, EU MDR Class IIa, and Singapore HSA clearances across multiple product generations.

The company's product architecture is a platform-plus-modules model centered on the UbiqVue Wireless Patient Monitoring System (Bioweb Platform). Two ready-to-deploy applications anchor the offering: UbiqVue Multiparameter for continuous vital sign monitoring (2-channel ECG, SpO2, respiration rate, temperature, pulse rate, posture, motion) in hospital and hospital-at-home settings, and UbiqVue Holter for cloud-based ambulatory ECG analysis and reporting. The platform is powered by five disposable chest-worn biosensor variants (1AX, 1AXe, 2A, 2AY, 2AYe) addressing Holter, MCT, and multiparameter use cases. SpO2 White Light Spectral technology is licensed from BioIntelliSense. Semiconductor fabrication is handled by STMicroelectronics and biosensor assembly by Dreamtech, enabling high-volume production of the single-chip disposable design.

LifeSignals generates revenue through a combination of disposable biosensor hardware sales, pay-per-use Holter service contracts, OEM integration and licensing agreements (APIs and reference designs), and subscription access to the UbiqVue cloud platform. The company serves hospital systems, cardiology practices, independent diagnostic testing facilities, skilled nursing facilities, telehealth providers, and healthtech OEMs across the US, India, Philippines, Ukraine, the UK, Singapore, and the EU. Distribution combines direct enterprise sales with channel partnerships — UltraGreen Cardiac Technologies for global distribution of the Holter biosensors and UltraLinQ for cardiac monitoring — plus an OEM Integration program for third-party healthtech platforms. LifeSignals has 11-50 employees, has raised approximately $15.7M in disclosed funding through 2016, and has accelerated commercial activity since 2024 with FDA and EU MDR approvals of the UbiqVue 2A Multiparameter System and a global distribution partnership with UltraGreen in April 2026.

Short descriptiontext

LifeSignals is a private medical device company that develops disposable wireless biosensors and the UbiqVue cloud patient monitoring platform for continuous clinical-grade vital sign capture across hospital, ambulatory, and home care settings.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersMilpitas, United States
HQ citystring
Milpitas
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
wearable biosensor technology, remote patient monitoring, cardiac monitoring devices, medical device manufacturing, wireless health technology
Industry2 codes
PRIMARYHLAHACAA
Vital Signs Monitoring (Multi-parameter, Spot-Check & Continuous)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLACAPAB
Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Wearable Medical Biosensors
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model4 records
1Disposable Wearable Biosensors
TypeHardware Sales
Description

Single-use, disposable chest-worn biosensors sold to healthcare providers for patient monitoring. The biosensors capture clinical-grade physiological data and transmit to cloud servers. Revenue generated through unit sales of biosensors across Holter and Multiparameter product lines.

lifesignals.com
2Cloud-Based Software Platform
TypeSubscription Recurring
Description

UbiqVue cloud-based portal for patient monitoring, data analysis, and report generation. Healthcare providers access continuous vital signs, alerts, and patient reports through subscription or service-based access.

lifesignals.com
3OEM Integration Services
TypeProfessional Services
Description

Fast-track solutions with APIs, reference designs, and regulatory clearances for OEM partners with high-volume distribution requirements. Includes hardware, software, regulatory, consulting, and manufacturing support services.

lifesignals.com
4Pay-per-Use Model
TypeUsage Based
Description

Flexible pay-per-use model for Holter monitoring services allowing flexibility with minimal investment. No servicing or maintenance costs for healthcare providers.

lifesignals.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure
Pricing details2 tiers
1Pay-per-use model for Holter monitoring services
ModelUsage-basedBilling cadencePay-as-you-go
Notes

Flexible pay-per-use model allowing flexibility with minimal investment. No servicing or maintenance costs involved.

lifesignals.com
2OEM Integration for high-volume distribution
ModelOtherBilling cadenceMulti-year contract
Notes

Fast-track solutions available for OEM Partners with high-volume distribution requirements. Pricing likely negotiated based on volume and integration scope.

lifesignals.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

LifeSignals designs, manufactures, and sells disposable, single-use wireless wearable biosensors and a cloud-based patient monitoring platform (UbiqVue) that capture and transmit clinical-grade vital sign data (ECG, SpO2, respiration, temperature, motion) to healthcare providers for continuous monitoring across hospital, ambulatory, and home settings. Its portfolio includes the LifeSignals Processor (LSP) silicon platform, multiple chest-worn biosensor variants, and integrated Holter and Multiparameter systems, sold via direct sales, channel partners, and an OEM integration program.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 11 values shown
  • Reduced first-30-day hospital readmissions from 21% to 5% for skilled nursing facilities
+10 more records
Product overview1 text field

LifeSignals offers a platform-plus-modules product architecture centered on the UbiqVue Wireless Patient Monitoring System (Bioweb Platform). The core platform collects, stores, transmits, analyzes, and reports near real-time biodata from patients in clinical and community settings. Two ready-to-deploy applications form the primary product lines: UbiqVue Multiparameter System for continuous vital sign monitoring (including SpO2, ECG, respiration rate, temperature) in hospital and at-home care, and UbiqVue Holter System for cloud-based ECG monitoring, analysis and reporting. The platform is enabled by five disposable chest-worn biosensor variants (1AXe, 2AYe, 1AX, 2AY, 2A) and three integration products (Multiparameter Integrate, Holter Integrate, MCT Integrate) for OEM partners. The underlying LifeSignals Processor (LSP) System-on-a-Chip platform powers all biosensors with patented single-chip wireless technology.

Product and service12 records
1UbiqVue Multiparameter System
CategoryWireless Patient Monitoring System
Description

Continuous near real-time vital sign monitoring system that captures clinical-grade SpO2, 2-channel ECG, respiration rate, temperature, and motion via disposable biosensors and streams data securely to the cloud for clinical intelligence in hospitals and at-home care.

2UbiqVue Holter System
CategoryCardiac Monitoring System
Description

Cloud-based Holter ECG monitoring, analysis, and reporting solution for large-scale healthcare providers and ambulatory cardiac monitoring facilities, integrating wearable ECG biosensors with hassle-free workflow and zero device returns.

3UbiqVue Wireless Patient Monitoring Platform (Bioweb)
CategoryCloud-based Monitoring Platform
Description

An ecosystem that collects, stores, transmits, analyzes, and reports near real-time biodata from patients in community and clinical settings, including ready-to-deploy applications and integration systems for healthcare providers.

4LifeSignals Processor (LSP) System-on-a-Chip Platform
CategorySemiconductor Platform
Description

Patented single-use, wireless SoC platform that integrates continuous signal acquisition, storage, processing, and transmission in a single chip, supporting multiple vital signs including heart rate, respiration rate, temperature, SpO2, and ECG.

5UbiqVue 2A Biosensor
CategoryDisposable Wearable Biosensor
Description

Single-use, all-in-one, chest-worn medical device that continuously collects and transmits SpO2, 2-channel ECG, pulse rate, PPG, respiration rate, body temperature, and motion data in near real-time to the cloud.

6UbiqVue 2AY Biosensor
CategoryDisposable Wearable Biosensor
Description

Single-use, chest-worn medical device for continuous patient monitoring that captures 2-channel ECG, pulse rate, PPG, respiration rate, body and skin temperature, R-R interval, posture, and motion data, transmitting in near real-time to the cloud.

7UbiqVue 1AX Biosensor
CategoryDisposable Wearable Biosensor
Description

Single-use, chest-worn multiparameter biosensor for active patient monitoring that continuously collects and transmits 2-channel ECG, respiration rate, skin temperature, posture, and motion data to the cloud server.

8UbiqVue 2AYe Biosensor
CategoryDisposable Holter Biosensor
Description

Single-use, chest-worn Holter biosensor that continuously collects 2-channel ECG and event data for up to 8 days, with intermittent transfer to a secure server via Patient Mobile App or Relay Device.

9UbiqVue 1AXe Biosensor
CategoryDisposable Holter Biosensor
Description

Single-use, chest-worn Holter device that continuously collects 2-channel ECG and event data for up to 7 days, with data wirelessly transmitted via a Relay Bridge upon return to the clinical facility.

10UbiqVue MCT Integrate
CategoryOEM Integration Solution
Description

Wireless disposable Mobile Cardiac Telemetry system with regulatory clearances, designed for third-party integration, combining clinical-grade 2-channel ECG data with secure cloud architecture and APIs for MCT service providers.

11UbiqVue Holter Integrate
CategoryOEM Integration Solution
Description

Wireless single-use Holter solution with regulatory clearances available for third-party integration, designed for established Holter service providers and healthtech OEMs needing clinical-grade 2-channel ECG capture.

12UbiqVue Multiparameter Integrate
CategoryOEM Integration Solution
Description

Cloud-based continuous wireless patient monitoring system with regulatory clearances ready for third-party integration, enabling large-scale wireless patient monitoring in medical facilities and home environments via robust APIs.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-04-21
Description

Strategic partnership for global distribution of LifeSignals 1AXe and 2AYe cardiac monitoring biosensors for hospital systems, cardiology practices, and independent diagnostic testing facilities. Biosensors commercialized through UltraGreen's dedicated cardiac monitoring platform and UbiqVue Holter software platform with flexible commercial models including direct hardware supply and integrated service offerings. Partnership aims to address growing global burden of cardiovascular disease and increasing demand for wearable cardiac monitoring solutions.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-04-22
Description

Partnership at Heart Rhythm 2025 to launch UbiqVue Holter System. UltraLinQ serves as integration and distribution partner for cardiac monitoring solutions. Strategic collaboration for market expansion in cardiac monitoring sector.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Premier global semiconductor supplier with 11 main manufacturing sites. LifeSignals has been working with STMicroelectronics to industrialize low-cost, disposable, ultra-reliable wireless System-on-Chip (SoC) in high volumes while meeting clinical-grade requirements. ST provides support throughout design phases and production.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Global electronic manufacturing service company with facilities in Korea, Vietnam, and China. Dreamtech designs, develops, and produces essential modules for smartphone, automotive LED, home appliance, fingerprint, medical/healthcare, sensors, and IT convergence products. LifeSignals has been working with Dreamtech to assemble and manufacture wearable biosensors in high volumes while meeting clinical-grade requirements.

Strategic tierCoreTypeTechnology or Integration
Description

Licensed white light spectral SpO2 patented technology from BioIntelliSense, Inc. LifeSignals in partnership with BioIntelliSense carried out product-level design and processing technology enhancements enabling reliable, continuous SpO2 monitoring and accurate performance across all skin tones in a chest-worn biosensor.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

iRhythm is the most direct peer in single-use ambulatory cardiac monitoring with its Zio long-term continuous ECG patch and cloud-based analysis service. Both companies compete in clinical-grade disposable Holter/MCT products with cloud analytics for cardiology practices and IDTFs.

TypeDirect peer
Description

BioIntelliSense offers the BioButton and BioSticker continuous multi-parameter wearable biosensors for remote patient monitoring. It is both a competitor in clinical-grade wearable monitoring and a key technology partner (SpO2 white light spectral tech licensor) to LifeSignals.

TypeDirect peer
Description

Preventice offers BodyGuardian remote cardiac monitoring systems (MCT and Holter) and is now part of Boston Scientific. It directly competes with LifeSignals' UbiqVue Holter and MCT Integrate products in ambulatory cardiac monitoring for IDTFs and cardiology practices.

TypeEmerging player
Description

VivaLNK provides continuous remote patient monitoring wearable sensors (ECG patch, temperature, heart rate) for hospital and home settings with cloud platform. Overlaps with LifeSignals' multiparameter biosensor offering for RPM and clinical trials.

TypeBroad incumbent
Description

Masimo is a global leader in noninvasive monitoring technologies, including pulse oximetry and patient monitoring. Its broader portfolio (including acquired SpO2 technologies) competes with LifeSignals' wireless multiparameter biosensors in hospital continuous monitoring applications.

TypeBroad incumbent
Description

Philips acquired BioTelemetry to expand its remote cardiac monitoring services and now offers enterprise-scale ambulatory ECG/MCT solutions. It competes with LifeSignals at the integrated platform level across hospitals, IDTFs, and cardiology practices.

TypeBroad incumbent
Description

GE Healthcare provides a wide range of patient monitoring solutions including wireless and ambulatory monitoring in hospitals. It is an incumbent competitor as healthcare systems upgrade from tethered to wireless continuous monitoring infrastructure.

TypeEmerging player
Description

Caretaker Medical offers wireless continuous vital sign monitoring (CNAP, cuffless blood pressure, ECG) using finger/wrist sensors for hospital and remote settings. It is a smaller competitor in continuous wireless patient monitoring with partial feature overlap to LifeSignals' multiparameter system.

TypeEmerging player
Description

SmartCardia provides a wearable ECG and vital signs patch with AI-driven analytics for hospital RPM and clinical trials. It is an emerging competitor in chest-worn wireless biosensors with overlapping use cases in cardiac monitoring and remote patient care.

TypeBroad incumbent
Description

Hillrom (acquired by Baxter) provides connected care solutions including patient monitoring systems for hospitals. It competes as a broader incumbent in wireless patient monitoring infrastructure alongside LifeSignals' multiparameter offerings.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance8 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

LifeSignals

Wearable Medical Biosensorslifesignals.com

LifeSignals is a private medical device company that develops disposable wireless biosensors and the UbiqVue cloud patient monitoring platform for continuous clinical-grade vital sign capture across hospital, ambulatory, and home care settings.

What LifeSignals does

LifeSignals is a privately held medical device company headquartered in Milpitas, California, with an engineering and operations center in Bangalore, India. Founded in 2006, the company designs and manufactures clinical-grade disposable wireless biosensors and the UbiqVue cloud-based patient monitoring platform for continuous vital sign capture across hospital, ambulatory, and home care settings. Its core technical asset is the LifeSignals Processor (LSP), a patented single-use wireless System-on-Chip that integrates a Wi-Fi-centric multi-radio (with Bluetooth, MBAN, and UWB), an ARM Cortex-M0 processor, onboard data storage, and AES encryption onto a single chip. The company holds 20+ patents in the US, UK, and Europe and has secured FDA 510(k), CE Mark, EU MDR Class IIa, and Singapore HSA clearances across multiple product generations.

The company's product architecture is a platform-plus-modules model centered on the UbiqVue Wireless Patient Monitoring System (Bioweb Platform). Two ready-to-deploy applications anchor the offering: UbiqVue Multiparameter for continuous vital sign monitoring (2-channel ECG, SpO2, respiration rate, temperature, pulse rate, posture, motion) in hospital and hospital-at-home settings, and UbiqVue Holter for cloud-based ambulatory ECG analysis and reporting. The platform is powered by five disposable chest-worn biosensor variants (1AX, 1AXe, 2A, 2AY, 2AYe) addressing Holter, MCT, and multiparameter use cases. SpO2 White Light Spectral technology is licensed from BioIntelliSense. Semiconductor fabrication is handled by STMicroelectronics and biosensor assembly by Dreamtech, enabling high-volume production of the single-chip disposable design.

LifeSignals generates revenue through a combination of disposable biosensor hardware sales, pay-per-use Holter service contracts, OEM integration and licensing agreements (APIs and reference designs), and subscription access to the UbiqVue cloud platform. The company serves hospital systems, cardiology practices, independent diagnostic testing facilities, skilled nursing facilities, telehealth providers, and healthtech OEMs across the US, India, Philippines, Ukraine, the UK, Singapore, and the EU. Distribution combines direct enterprise sales with channel partnerships — UltraGreen Cardiac Technologies for global distribution of the Holter biosensors and UltraLinQ for cardiac monitoring — plus an OEM Integration program for third-party healthtech platforms. LifeSignals has 11-50 employees, has raised approximately $15.7M in disclosed funding through 2016, and has accelerated commercial activity since 2024 with FDA and EU MDR approvals of the UbiqVue 2A Multiparameter System and a global distribution partnership with UltraGreen in April 2026.

LifeSignals firmographics

Firmographics
Name
LifeSignals
Legal name
LifeSignals Group, Inc.
Website
https://lifesignals.com
Company type
Private
Founded year
2008
Operating status
Operating
Headcount range
101–250 employees
Short description
LifeSignals is a private medical device company that develops disposable wireless biosensors and the UbiqVue cloud patient monitoring platform for continuous clinical-grade vital sign capture across hospital, ambulatory, and home care settings.
Ownership category
akta.pro rank

LifeSignals industry classification

Industry
Product category
Wearable Medical Biosensors
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHACAA
Vital Signs Monitoring (Multi-parameter, Spot-Check & Continuous)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLACAPAB
Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring

Keywords

  • Wearable biosensor technology
  • Remote patient monitoring
  • Cardiac monitoring devices
  • Medical device manufacturing
  • Wireless health technology

Where LifeSignals is headquartered

Location

Headquarters

HQ city
Milpitas
HQ country
United States
HQ region
North America

Offices2 records

Markets served

LifeSignals business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Disposable Wearable Biosensors: Single-use, disposable chest-worn biosensors sold to healthcare providers for patient monitoring. The biosensors capture clinical-grade physiological data and transmit to cloud servers. Revenue generated through unit sales of biosensors across Holter and Multiparameter product lines.
  2. Cloud-Based Software Platform: UbiqVue cloud-based portal for patient monitoring, data analysis, and report generation. Healthcare providers access continuous vital signs, alerts, and patient reports through subscription or service-based access.
  3. OEM Integration Services: Fast-track solutions with APIs, reference designs, and regulatory clearances for OEM partners with high-volume distribution requirements. Includes hardware, software, regulatory, consulting, and manufacturing support services.
  4. Pay-per-Use Model: Flexible pay-per-use model for Holter monitoring services allowing flexibility with minimal investment. No servicing or maintenance costs for healthcare providers.

Pricing tiers

ModelBillingPrice
Usage-basedPay-as-you-goPay-per-use model for Holter monitoring services
OtherMulti-year contractOEM Integration for high-volume distribution

Go-to-market motion4 records

Distribution channels5 records

Marketing channels6 records

LifeSignals product offering

Product offering

Core offering

LifeSignals designs, manufactures, and sells disposable, single-use wireless wearable biosensors and a cloud-based patient monitoring platform (UbiqVue) that capture and transmit clinical-grade vital sign data (ECG, SpO2, respiration, temperature, motion) to healthcare providers for continuous monitoring across hospital, ambulatory, and home settings. Its portfolio includes the LifeSignals Processor (LSP) silicon platform, multiple chest-worn biosensor variants, and integrated Holter and Multiparameter systems, sold via direct sales, channel partners, and an OEM integration program.

Product overview

LifeSignals offers a platform-plus-modules product architecture centered on the UbiqVue Wireless Patient Monitoring System (Bioweb Platform). The core platform collects, stores, transmits, analyzes, and reports near real-time biodata from patients in clinical and community settings. Two ready-to-deploy applications form the primary product lines: UbiqVue Multiparameter System for continuous vital sign monitoring (including SpO2, ECG, respiration rate, temperature) in hospital and at-home care, and UbiqVue Holter System for cloud-based ECG monitoring, analysis and reporting. The platform is enabled by five disposable chest-worn biosensor variants (1AXe, 2AYe, 1AX, 2AY, 2A) and three integration products (Multiparameter Integrate, Holter Integrate, MCT Integrate) for OEM partners. The underlying LifeSignals Processor (LSP) System-on-a-Chip platform powers all biosensors with patented single-chip wireless technology.

Differentiator

Problem solved

Functional benefit

Products and services

  • UbiqVue Multiparameter System Continuous near real-time vital sign monitoring system that captures clinical-grade SpO2, 2-channel ECG, respiration rate, temperature, and motion via disposable biosensors and streams data securely to the cloud for clinical intelligence in hospitals and at-home care.
  • UbiqVue Holter System Cloud-based Holter ECG monitoring, analysis, and reporting solution for large-scale healthcare providers and ambulatory cardiac monitoring facilities, integrating wearable ECG biosensors with hassle-free workflow and zero device returns.
  • UbiqVue Wireless Patient Monitoring Platform (Bioweb) An ecosystem that collects, stores, transmits, analyzes, and reports near real-time biodata from patients in community and clinical settings, including ready-to-deploy applications and integration systems for healthcare providers.
  • LifeSignals Processor (LSP) System-on-a-Chip Platform Patented single-use, wireless SoC platform that integrates continuous signal acquisition, storage, processing, and transmission in a single chip, supporting multiple vital signs including heart rate, respiration rate, temperature, SpO2, and ECG.
  • UbiqVue 2A Biosensor Single-use, all-in-one, chest-worn medical device that continuously collects and transmits SpO2, 2-channel ECG, pulse rate, PPG, respiration rate, body temperature, and motion data in near real-time to the cloud.
  • UbiqVue 2AY Biosensor Single-use, chest-worn medical device for continuous patient monitoring that captures 2-channel ECG, pulse rate, PPG, respiration rate, body and skin temperature, R-R interval, posture, and motion data, transmitting in near real-time to the cloud.
  • UbiqVue 1AX Biosensor Single-use, chest-worn multiparameter biosensor for active patient monitoring that continuously collects and transmits 2-channel ECG, respiration rate, skin temperature, posture, and motion data to the cloud server.
  • UbiqVue 2AYe Biosensor Single-use, chest-worn Holter biosensor that continuously collects 2-channel ECG and event data for up to 8 days, with intermittent transfer to a secure server via Patient Mobile App or Relay Device.
  • UbiqVue 1AXe Biosensor Single-use, chest-worn Holter device that continuously collects 2-channel ECG and event data for up to 7 days, with data wirelessly transmitted via a Relay Bridge upon return to the clinical facility.
  • UbiqVue MCT Integrate Wireless disposable Mobile Cardiac Telemetry system with regulatory clearances, designed for third-party integration, combining clinical-grade 2-channel ECG data with secure cloud architecture and APIs for MCT service providers.
  • UbiqVue Holter Integrate Wireless single-use Holter solution with regulatory clearances available for third-party integration, designed for established Holter service providers and healthtech OEMs needing clinical-grade 2-channel ECG capture.
  • UbiqVue Multiparameter Integrate Cloud-based continuous wireless patient monitoring system with regulatory clearances ready for third-party integration, enabling large-scale wireless patient monitoring in medical facilities and home environments via robust APIs.

Quantifiable outcome

  • Reduced first-30-day hospital readmissions from 21% to 5% for skilled nursing facilities
  • +10 more outcomes

Companies that use LifeSignals

Customer profile

Named customers8 records

Segments4 records

Ideal customer profiles4 records

LifeSignals technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature7 records

LifeSignals partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core.

  • UltraGreen Cardiac TechnologiescoreChannel Partner/ Reseller/ Distributor · 21 April 2026Strategic partnership for global distribution of LifeSignals 1AXe and 2AYe cardiac monitoring biosensors for hospital systems, cardiology practices, and independent diagnostic testing facilities. Biosensors commercialized through UltraGreen's dedicated cardiac monitoring platform and UbiqVue Holter software platform with flexible commercial models including direct hardware supply and integrated service offerings. Partnership aims to address growing global burden of cardiovascular disease and increasing demand for wearable cardiac monitoring solutions.
  • UltraLinQcoreStrategic or Co-development Partner · 22 April 2025Partnership at Heart Rhythm 2025 to launch UbiqVue Holter System. UltraLinQ serves as integration and distribution partner for cardiac monitoring solutions. Strategic collaboration for market expansion in cardiac monitoring sector.
  • STMicroelectronicscoreOEM/ Whitelabel/ Licensing PartnerPremier global semiconductor supplier with 11 main manufacturing sites. LifeSignals has been working with STMicroelectronics to industrialize low-cost, disposable, ultra-reliable wireless System-on-Chip (SoC) in high volumes while meeting clinical-grade requirements. ST provides support throughout design phases and production.
  • DreamtechcoreOEM/ Whitelabel/ Licensing PartnerGlobal electronic manufacturing service company with facilities in Korea, Vietnam, and China. Dreamtech designs, develops, and produces essential modules for smartphone, automotive LED, home appliance, fingerprint, medical/healthcare, sensors, and IT convergence products. LifeSignals has been working with Dreamtech to assemble and manufacture wearable biosensors in high volumes while meeting clinical-grade requirements.
  • BioIntelliSensecoreTechnology or IntegrationLicensed white light spectral SpO2 patented technology from BioIntelliSense, Inc. LifeSignals in partnership with BioIntelliSense carried out product-level design and processing technology enhancements enabling reliable, continuous SpO2 monitoring and accurate performance across all skin tones in a chest-worn biosensor.

Scale indicators8 records

Recent moves6 records

Expansion highlights7 records

LifeSignals competitors and assessment

Company assessment

Direct peers

  • iRhythm Technologies: iRhythm is the most direct peer in single-use ambulatory cardiac monitoring with its Zio long-term continuous ECG patch and cloud-based analysis service. Both companies compete in clinical-grade disposable Holter/MCT products with cloud analytics for cardiology practices and IDTFs.
  • BioIntelliSense: BioIntelliSense offers the BioButton and BioSticker continuous multi-parameter wearable biosensors for remote patient monitoring. It is both a competitor in clinical-grade wearable monitoring and a key technology partner (SpO2 white light spectral tech licensor) to LifeSignals.
  • Preventice Solutions (Boston Scientific): Preventice offers BodyGuardian remote cardiac monitoring systems (MCT and Holter) and is now part of Boston Scientific. It directly competes with LifeSignals' UbiqVue Holter and MCT Integrate products in ambulatory cardiac monitoring for IDTFs and cardiology practices.

Emerging players

  • VivaLNK: VivaLNK provides continuous remote patient monitoring wearable sensors (ECG patch, temperature, heart rate) for hospital and home settings with cloud platform. Overlaps with LifeSignals' multiparameter biosensor offering for RPM and clinical trials.
  • Caretaker Medical: Caretaker Medical offers wireless continuous vital sign monitoring (CNAP, cuffless blood pressure, ECG) using finger/wrist sensors for hospital and remote settings. It is a smaller competitor in continuous wireless patient monitoring with partial feature overlap to LifeSignals' multiparameter system.
  • SmartCardia: SmartCardia provides a wearable ECG and vital signs patch with AI-driven analytics for hospital RPM and clinical trials. It is an emerging competitor in chest-worn wireless biosensors with overlapping use cases in cardiac monitoring and remote patient care.

Broad incumbents

  • Masimo: Masimo is a global leader in noninvasive monitoring technologies, including pulse oximetry and patient monitoring. Its broader portfolio (including acquired SpO2 technologies) competes with LifeSignals' wireless multiparameter biosensors in hospital continuous monitoring applications.
  • Philips (BioTelemetry): Philips acquired BioTelemetry to expand its remote cardiac monitoring services and now offers enterprise-scale ambulatory ECG/MCT solutions. It competes with LifeSignals at the integrated platform level across hospitals, IDTFs, and cardiology practices.
  • GE Healthcare: GE Healthcare provides a wide range of patient monitoring solutions including wireless and ambulatory monitoring in hospitals. It is an incumbent competitor as healthcare systems upgrade from tethered to wireless continuous monitoring infrastructure.
  • Hillrom (now Baxter): Hillrom (acquired by Baxter) provides connected care solutions including patient monitoring systems for hospitals. It competes as a broader incumbent in wireless patient monitoring infrastructure alongside LifeSignals' multiparameter offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

LifeSignals social profiles

Digital presence

LifeSignals compliance and trust

Trust signal

Compliance8 records

LifeSignals financial estimates

Financial estimate

Revenue estimate

Valuation estimate

LifeSignals leadership team

Management profile

Number of profiles

Profiles8 records

LifeSignals subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

LifeSignals funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

LifeSignals M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LifeSignals

What does LifeSignals do?

LifeSignals designs, manufactures, and sells disposable, single-use wireless wearable biosensors and a cloud-based patient monitoring platform (UbiqVue) that capture and transmit clinical-grade vital sign data (ECG, SpO2, respiration, temperature, motion) to healthcare providers for continuous monitoring across hospital, ambulatory, and home settings. Its portfolio includes the LifeSignals Processor (LSP) silicon platform, multiple chest-worn biosensor variants, and integrated Holter and Multiparameter systems, sold via direct sales, channel partners, and an OEM integration program.

Is LifeSignals a public or private company?

LifeSignals is a private company. It is classified as venture growth investor backed and is currently operating.

When was LifeSignals founded?

LifeSignals was founded in 2008. It employs 101 to 250 people.

Where is LifeSignals based?

LifeSignals is headquartered in Milpitas, United States, in the North America region.

How does LifeSignals make money?

Four revenue lines are on record. Disposable Wearable Biosensors are the primary driver. The others are cloud-Based Software Platform, OEM Integration Services and pay-per-Use Model.

Who are LifeSignals's main competitors?

Direct peers on record are iRhythm Technologies, BioIntelliSense and Preventice Solutions (Boston Scientific). Emerging players are VivaLNK, Caretaker Medical and SmartCardia. Broad incumbents are Masimo, Philips (BioTelemetry), GE Healthcare and Hillrom (now Baxter).

Does LifeSignals have an API?

Yes. LifeSignals offers APIs and SDKs for integration into third-party healthcare systems. The UbiqVue Integrate systems provide robust APIs for seamless integration into existing healthcare delivery systems. The platform enables access to near real-time vital sign data, EWS (Early Warning Scores), and clinical alerts from UbiqVue Cloud Server. LifeSignals Technical Support Team provides comprehensive support for integration. The interoperable platform is fully customizable and suitable for any scale implementation. System components include UbiqVue Holter Web Server (UA2251-W), UbiqVue Holter Web Portal (UA2251-C), UbiqVue Holter Analyzer Server and Desktop (UA2251-SA and UA2251-DA), UbiqVue Holter App (UA2251-R), and UbiqVue Holter Central Server (UA2251-S).

What industry is LifeSignals in?

LifeSignals's product category is Wearable Medical Biosensors. Its primary akta.pro industry code is HLAHACAA, Vital Signs Monitoring (Multi-parameter, Spot-Check & Continuous), with a secondary code of HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MarketScreenerRoyal Philips, Blue Spark Technologies, Caretaker Medical, Cuviva, LifeSignals, Respiree And smartQare Expand Open Patient Monitoring Ecosystem To Help Health Systems Keep Sight Of Patients Beyond TheRoyal Philips announced new collaborations with Blue Spark Technologies, Caretaker Medical, Cuviva, LifeSignals, Respiree, and smartQare to expand its open patient monitoring ecosystem. These partnerships integrate wearable and out-of-hospital technologies into the Philips platform, enabling health systems to improve continuity of care from hospital to home through interoperable data integration.GlobeNewswirePhilips expands open patient monitoring ecosystem to help health systems keep sight of patients beyond the bedsidePhilips announced new collaborations with Blue Spark, Caretaker, Cuviva, LifeSignals, Respiree, and smartQare to expand its open monitoring ecosystem. The partnerships integrate wearable and out-of-hospital devices like temperature patches, blood pressure monitors, and cardio-respiratory biosensors into Philips' Patient Information Center iX. The goal is to support continuous patient monitoring from hospital to home.Mpo-magPhilips Expands its Open Patient Monitoring EcosystemPhilips announced new collaborations with Blue Spark, Caretaker, Cuviva, LifeSignals, Respiree, and smartQare to expand its open patient monitoring ecosystem. The partnerships integrate wearable and out-of-hospital technologies, including temperature, blood pressure, and cardio-respiratory monitoring, to support continuous care from hospital to home.PR NewswireUltraGreen Cardiac Technologies launches Partnership with LifeSignals to Expand Access to Advanced Wearable Cardiac Monitoring Biosensors GloballyUltraGreen Cardiac Technologies, a business unit of UltraGreen.ai, announced a strategic partnership with LifeSignals to globally distribute LifeSignals' 1AXe and 2AYe cardiac monitoring biosensors for hospital systems, cardiology practices, and independent diagnostic testing facilities. The biosensors will be commercialized through UltraGreen's dedicated cardiac monitoring platform and enabled via the UbiqVue™ Holter software platform, with flexible commercial models including direct hardware supply and integrated service offerings. The partnership aims to address the growing global burden of cardiovascular disease and increasing demand for wearable cardiac monitoring solutions.LifesignalsWearable Biosensors for Remote Patient MonitoringThe article describes the UbiqVue wearable biosensor system, a single-use medical device that continuously collects physiological data such as ECG and core biodata for remote patient monitoring. Developed by LifeSignals, Inc., the system transmits this information to a cloud server for analysis by healthcare professionals via a web portal. Clinical studies cited in the text highlight high patient comfort, reliable data retrieval, and zero packet loss during continuous wear periods.Mpo-magLifeSignals Introduces the UbiqVue Holter SystemLifeSignals Inc. has launched the UbiqVue 2AYe Holter System, a digital cardiac monitoring solution that transmits encrypted ECG data directly to a cloud-based system to accelerate diagnostic report delivery. The system utilizes single-use chest-worn biosensors and will be distributed by UltraLinQ Healthcare Solutions to streamline workflows and eliminate device retrieval logistics.The Manila TimesLifeSignals Receives FDA 510(k) Approval for UbiqVue™ 2A Multiparameter SystemLifeSignals, Inc. received FDA Class II 510(k) clearance for its UbiqVue™ 2A Multiparameter System, a cloud-based platform featuring a wearable biosensor that continuously monitors twelve physiological parameters including SpO2 and ECG. The system enables active patient monitoring across hospital and home settings by replacing manual spot checks with near real-time data transmission to healthcare providers. This approval supports LifeSignals' strategy to scale population health management solutions through global partnerships.The Times of IndiaLifeSigns partners with Amala Hospital, launches smart wardAmala Hospital has partnered with health-tech startup LifeSigns to launch a smart ward equipped with wireless patient monitoring technology in Thrissur, Kerala. The initiative aims to improve patient outcomes and reduce medical errors by providing continuous real-time monitoring of vital signs without the need for traditional wired systems.PR NewswireLifeSignals obtient l'approbation 510 (k) de la FDA pour sa plateforme de télésurveillance multiparamétrique LifeSignals LX1550LifeSignals Inc. announced on July 28, 2021 that its LifeSignals LX1550 multiparametric remote monitoring platform received FDA 510(k) clearance for Class II medical devices. The platform features a disposable wireless biosensor that continuously records two-channel ECG, heart rate, respiratory rate, skin temperature, and body posture for up to five days, transmitting encrypted data to a cloud-based monitoring dashboard. The company has already successfully deployed the platform in hospitals for COVID-19 patient monitoring in India, Europe, the United Kingdom, Singapore, and the Philippines, and now aims to expand into the US health technology market.PR NewswireLifeSignals erhält FDA 510 (k)-Zulassung für die Multiparameter-Fernüberwachungsplattform LifeSignals LX1550LifeSignals Inc. received FDA 510(k) Class II clearance for its LifeSignals LX1550 multi-parameter remote monitoring platform, following earlier CE marking approval. The platform features a disposable biosensor that continuously records 2-channel ECG, heart rate, respiratory rate, skin temperature, and body posture for up to five days, transmitting encrypted data to a cloud-based dashboard via a relay app. The system has already been deployed for COVID-19 patient monitoring in Indian hospitals and is being rolled out across Europe, the UK, Singapore, and the Philippines, with plans to expand to US healthcare providers.